Cargando…
Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) is an emerging prostate cancer imaging method, which has been reported to have a higher sensitivity and specificity than the currently approved PET imaging agents. Multiple PSMA ligands are being investigated aroun...
Autores principales: | Czarniecki, Marcin, Mena, Esther, Lindenberg, Liza, Cacko, Marek, Harmon, Stephanie, Radtke, Jan Philipp, Giesel, Frederick, Turkbey, Baris, Choyke, Peter L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212618/ https://www.ncbi.nlm.nih.gov/pubmed/30456186 http://dx.doi.org/10.21037/tau.2018.08.03 |
Ejemplares similares
-
Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
por: Bednarova, Sandra, et al.
Publicado: (2017) -
Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
por: Czarniecki, Marcin, et al.
Publicado: (2018) -
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
por: Rowe, Lindsay S., et al.
Publicado: (2021) -
A comparison of prostate cancer bone metastases on (18)F-Sodium Fluoride and Prostate Specific Membrane Antigen ((18)F-PSMA) PET/CT: Discordant uptake in the same lesion
por: Harmon, Stephanie A., et al.
Publicado: (2018) -
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options
por: Chaurasia, Avinash R, et al.
Publicado: (2020)